These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Current status and perspective of regenerative medicine for diabetic nephropathy]. Matsui S; Osafune K Nihon Rinsho; 2016 Apr; 74 Suppl 2():207-11. PubMed ID: 27266089 [No Abstract] [Full Text] [Related]
4. Small molecules and small molecule drugs in regenerative medicine. Lu B; Atala A Drug Discov Today; 2014 Jun; 19(6):801-8. PubMed ID: 24252867 [TBL] [Abstract][Full Text] [Related]
5. iPS cell technology-based research for the treatment of diabetic nephropathy. Osafune K Semin Nephrol; 2012 Sep; 32(5):479-85. PubMed ID: 23062989 [TBL] [Abstract][Full Text] [Related]
6. Stem cells: promises versus limitations. Choumerianou DM; Dimitriou H; Kalmanti M Tissue Eng Part B Rev; 2008 Mar; 14(1):53-60. PubMed ID: 18454634 [TBL] [Abstract][Full Text] [Related]
8. Cell therapy for diabetic nephropathy: is the future, now? Gilbert RE; Zhang Y; Yuen DA Semin Nephrol; 2012 Sep; 32(5):486-93. PubMed ID: 23062990 [TBL] [Abstract][Full Text] [Related]
9. Introduction to regenerative medicine and tissue engineering. Stoltz JF; Decot V; Huseltein C; He X; Zhang L; Magdalou J; Li YP; Menu P; Li N; Wang YY; de Isla N; Bensoussan D Biomed Mater Eng; 2012; 22(1-3):3-16. PubMed ID: 22766697 [TBL] [Abstract][Full Text] [Related]
10. Stem cells: a promising source for vascular regenerative medicine. Rammal H; Harmouch C; Lataillade JJ; Laurent-Maquin D; Labrude P; Menu P; Kerdjoudj H Stem Cells Dev; 2014 Dec; 23(24):2931-49. PubMed ID: 25167472 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of human adipose-derived stem cells in neurological disorders. Chang KA; Lee JH; Suh YH J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785 [TBL] [Abstract][Full Text] [Related]
14. Stem cell therapy, regenerative medicine and hematopoietic stem cell transplantation: recent achievements. Perseghin P Transfus Apher Sci; 2012 Oct; 47(2):191-2. PubMed ID: 22770809 [No Abstract] [Full Text] [Related]
15. Importance of controlled delivery systems for regenerative therapeutics. Khang G; Tripathy N Ther Deliv; 2014 Oct; 5(10):1053-5. PubMed ID: 25418264 [No Abstract] [Full Text] [Related]
16. How do we assess regenerative success after stem cell implantation? An experimental approach. Hoehn M Regen Med; 2011 Jul; 6(4):417-9. PubMed ID: 21749198 [No Abstract] [Full Text] [Related]
17. Era of stem cell therapy for regenerative medicine and cancers: an introduction for the special issue of Pan Pacific Symposium on Stem Cells and Cancer Research. Lin SZ Cell Transplant; 2015; 24(3):311-2. PubMed ID: 25671695 [No Abstract] [Full Text] [Related]
18. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials. Mizuno H Curr Opin Mol Ther; 2010 Aug; 12(4):442-9. PubMed ID: 20677095 [TBL] [Abstract][Full Text] [Related]
19. Nanoscaffold based stem cell regeneration therapy: recent advancement and future potential. Prakash S; Khan A; Paul A Expert Opin Biol Ther; 2010 Dec; 10(12):1649-61. PubMed ID: 20954792 [TBL] [Abstract][Full Text] [Related]
20. [Research development of amniotic fluid-derived stem cells in regenerative medicine]. Li C; Li W; Liu H; Wang J Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Oct; 27(10):1262-6. PubMed ID: 24397143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]